1888PressRelease.com

Biosyn.com - Biosynthesis Company News Section

Biosynthesis Press Release -

Biosyn.com

Bio-synthesis Is Excited To Announce The Recent Publication Validating The Use Of BNA Oligos In A Novel Bead-base Suspension Assay
Bridged Nucleic Acids used in the bead-based suspension assay prove superior hybridization.
July 11, 2014

Bio-Synthesis Announces New Chief Scientific Officer
Dr. Andrei Laikhter joins management team at Bio-Synthesis, Inc.
March 21, 2014

Bio-synthesis Inc. Pioneers The Use Of Multi Functional Bridged Nucleic Acid For Diagnostic, Clinical, And Therapeutic Applications
The next generation of nucleic acids, provided by Bio-Synthesis, is an ideal solution for the detection of small or highly similar DNA or RNA targets.
August 27, 2013

Bio-Synthesis Supports Local Scientific Meeting at TWU
As a community leader in the Dallas-Fort Worth area, Bio-Synthesis helps sponsor the scientific meeting at Texas Women's University.
April 11, 2013

Bio-Synthesis will Spotlight the New BNA Technology at AACR
Bridged Nucleic Acids exhibit increased stability in oligonucleotides.
March 21, 2013

Bio-Synthesis Inc. Announces a Superior IQ4 quencher for Dual Labeled Oligonucleotides
Instant Quenchers prove to be a better alternative to BHQ quenchers.
February 16, 2013

Bio-Synthesis Inc. Introduces "BNA-NC" - A Third Generation Multi Functional Bridged Nucleic Acid
Bio-Synthesis, Inc. has acquired a license from BNA Inc. of Osaka, Japan for the manufacturing and distribution of BNA-NC, a third generation of BNA oligonucleotides.
November 08, 2012

Bio-Synthesis Expands Proteomic Platform with Enhanced Peptide Tools
The inclusion of the Peptide Property Calculator and Peptide Library Design Tools enables researchers to make immediate adjustments to their projects.
February 01, 2012